Time-backed online marketing software producer Rokt pushed its valuation to $450m in a round led by TDM Growth Partners.

Takeda Ventures was among the investors as the cellular therapeutics developer launched with a round co-led by RA Capital Management and Atlas Venture.

The bioremediation technology startup is the first company to be launched through Ginkgo Bioworks' $350m Ferment Consortium.

Incubated by Vision Institute, the retinal disease gene therapy developer has secured $52.8m in a round co-led by UPMC Enterprises.

Intel Capital returned for the application development platform provider's series B round, hiking its overall funding to more than $60m.

The retinal disease gene therapy developer has secured $52.8m in a round co-led by UPMC Enterprises that will go toward further developing its drug pipeline.

TD Ameritrade and QBE-backed automation software producer Hyperscience has now raised in excess of $190m in total, Tiger Global Management leading its latest round.

Taiho Ventures and SR One co-led a series A round that will fund the early clinical progress of Dren's cancer and protein-depletion drug candidates.

Esenagro contributed to a round that lifted the vegan mince and meat producer's overall funding to nearly $80m in the past year.

Main Sequence Ventures, which co-founded the meat-free burger producer last year, has returned for a $55m series B round.